GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sumitomo Pharma Co 4506.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,914.5

+4.16%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥453.29bn

FY2017FY2026

Net income

¥106.86bn

FY2017FY2026

Free cash flow

¥67.11bn

FY2017FY2026

Shareholders' equity

¥292.47bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥453.29bn¥398.83bn¥314.56bn¥555.54bn¥560.03bn¥515.95bn¥482.73bn¥459.27bn¥466.84bn¥408.36bn
Research and development¥44.00bn¥49.87bn¥112.64bn¥131.86bn¥94.90bn¥97.24bn¥115.11bn¥102.36bn¥86.93bn¥81.37bn
Operating income¥50.34bn¥22.42bn−¥1.48bn¥11.20bn¥56.55bn¥68.38bn¥51.08bn¥57.21bn¥79.64bn¥60.97bn
Net income¥106.86bn¥23.63bn−¥314.97bn−¥74.51bn¥56.41bn¥56.22bn¥40.75bn¥48.63bn¥53.45bn¥31.32bn
Diluted earnings per share245.3159.49-792.79-187.55141.99141.51102.58122.40134.5378.82

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥804.57bn¥742.60bn¥907.51bn¥1.13trn¥1.31trn¥1.31trn¥1.25trn¥834.72bn¥809.68bn¥779.07bn
Cash and short-term investments¥44.31bn¥23.12bn¥29.05bn¥163.65bn¥202.98bn¥223.18bn¥130.43bn¥181.05bn¥147.78bn¥105.60bn
Total liabilities¥512.10bn¥573.13bn¥751.37bn¥727.96bn¥634.44bn¥659.95bn¥620.77bn¥336.58bn¥356.96bn¥366.80bn
Debt—¥314.25bn¥427.86bn¥346.37bn¥285.37bn¥291.55bn¥316.84bn¥32.98bn¥47.40bn¥68.00bn
Shareholders' equity¥292.47bn¥169.48bn¥156.06bn¥406.75bn¥607.89bn¥580.57bn¥529.49bn¥498.14bn¥452.72bn¥412.27bn
Shares outstanding436m397m397m397m397m397m397m397m397m397m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥71.72bn¥16.50bn−¥241.89bn¥11.94bn¥31.24bn¥135.60bn¥46.13bn¥48.71bn¥93.42bn¥19.14bn
Capital spending−¥4.61bn−¥8.50bn−¥10.77bn−¥12.74bn−¥13.49bn−¥10.81bn−¥13.35bn−¥9.27bn−¥5.13bn−¥8.13bn
Free cash flow¥67.11bn¥8.00bn−¥252.66bn−¥805.0m¥17.75bn¥124.80bn¥32.78bn¥39.45bn¥88.29bn¥11.01bn
Dividends paid−¥2.0m−¥3.0m−¥2.79bn−¥11.13bn−¥11.13bn−¥11.12bn−¥13.11bn−¥11.12bn−¥7.94bn−¥7.15bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥129.50bn¥105.55bn¥120.62bn¥119.12bn¥108.00bn¥105.65bn¥112.43bn¥90.07bn
Operating income¥17.41bn−¥4.90bn¥11.90bn¥23.28bn¥20.06bn¥3.29bn¥19.48bn−¥5.09bn
Net income¥17.00bn−¥812.0m¥8.82bn¥87.65bn¥11.21bn¥2.42bn¥53.45bn−¥48.17bn
Diluted earnings per share39.02-1.8622.19220.6328.216.08134.53-121.24
Cash from operations−¥7.44bn¥29.45bn¥24.24bn¥18.22bn−¥192.0m¥11.01bn¥939.0m¥29.61bn
Capital spending−¥663.0m−¥799.0m−¥1.29bn−¥1.05bn−¥1.47bn−¥2.38bn−¥2.06bn−¥1.76bn
Free cash flow−¥8.11bn¥28.65bn¥22.96bn¥17.17bn−¥1.67bn¥8.63bn−¥1.12bn¥27.84bn
Total assets¥844.88bn¥804.57bn¥815.52bn¥778.40bn¥733.33bn¥742.60bn¥852.12bn¥799.76bn
Cash and short-term investments¥76.64bn¥44.31bn¥57.32bn¥38.49bn¥20.45bn¥23.12bn¥85.39bn¥99.08bn
Debt¥41.00bn¥217.19bn—¥4.00bn¥50.19bn¥308.78bn¥254.96bn¥389.38bn
Shareholders' equity¥408.56bn¥292.47bn¥288.94bn¥265.59bn¥176.23bn¥169.48bn¥166.12bn¥114.17bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-6.6%-2.6%1.2%
Operating income65.0%-5.9%3.1%
Net income—13.7%15.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin8.5%4.8%7.4%9.8%
Net margin15.3%-15.0%-5.2%1.0%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings8.539.0-0.7-2.57.09.414.817.426.021.2
Price to sales2.02.30.70.30.71.01.31.83.01.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 30 Mar 2023.

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Paid in the year7.0028.0028.0028.0033.0018.0018.0018.00
  • 1-to-1 reverse split · 1 Oct 2005
  • 1.05-for-1 split · 26 Mar 1992
  • 1.05-for-1 split · 25 Sept 1991

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.